why choose us

First received: August 23, 2022

Clinical Trial: Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amyloidosis; Systemic

Study Type: INTERVENTIONAL


Official Title: A Three-part, Phase 1, Single-ascending, and Multiple-ascending Dose Escalation Study in Healthy Volunteers and Subjects With Systemic Amyloidosis to Assess the Safety, Tolerability, and Pharmacokinet

Brief Summary: This is a multicenter, international, three-part, Phase 1 study designed to evaluate the safety, tolerability, and PK of rising single doses of AT-02 in healthy volunteers and in subjects with systemic amyloidosis and to assess the safety, tolerability, and PK of multiple doses of AT-02 in subjects with systemic amyloidosis.

Read more